March's Most Popular Stories
By Andrew Briskin
-min.png)
In case you missed them, below you’ll find our top five stories from March 2022. This month’s best stories cover a wide variety of topics including a preview of upcoming diabetes technology, managing morning blood sugar levels, potential legislation lowering insulin costs, and more.
1. An Inside Look at the Dexcom G7
In March 2022, Dexcom announced that its next-generation continuous glucose monitor (CGM), Dexcom G7, took a significant step towards being available for use in Europe. Here is a look at the improvements over G6 and the expected timeline for launch in both Europe and the US.
2. How to Lower Morning Blood Sugar
Trying to learn how to lower morning blood sugar? Here’s why your glucose levels rise in the morning and a few things you can try to keep them in range.
3. $35 Insulin Price Cap Endorsed by President Biden in State of the Union Address
US pharmaceutical companies and insulin manufacturers react to proposed legislation that would cap insulin costs and prevent significant rises in the costs of prescription drugs.
4. Myth Busting Diabetes 'Cures'
Products claiming to treat or even cure diabetes are everywhere, but do these so-called ‘cures’ really work? Spoiler alert: the answer is usually no. Treatments for diabetes need to be FDA-approved to ensure they are safe and effective. However, products classified as dietary supplements are not regulated by the FDA. Below we discuss spices, dietary supplements, and other methods claiming to cure diabetes.
5. Tasty Southwest Chicken
These delicious chicken recipes will warm you up in the last days of winter, and they taste delicious. Whether you’re looking for a quick meal with few ingredients, or a more involved dish, Catherine Newman shares two recipes that can work for anyone.
